Telemus Capital, LLC Novartis Ag Transaction History

Telemus Capital, LLC

  • $1.2 Billion
  • Q4 2023

A detailed history of Telemus Capital, LLC transactions in Novartis Ag stock. As of the latest transaction made, Telemus Capital, LLC holds 8,122 shares of NVS stock, worth $846,962. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,122
Previous 9,809 17.2%
Holding current value
$846,962
Previous $999,000 17.92%
% of portfolio
0.07%
Previous 0.09%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024
SELL
$92.27 - $101.54 $155,659 - $171,297
-1,687 Reduced 17.2%
8,122 $820,000
Q3 2023

Oct 25, 2023
SELL
$94.73 - $105.13 $419,843 - $465,936
-4,432 Reduced 31.12%
9,809 $999,000
Q2 2023

Jul 10, 2023
SELL
$92.52 - $104.91 $70,500 - $79,941
-762 Reduced 5.08%
14,241 $1.44 Million
Q1 2023

Apr 11, 2023
SELL
$80.03 - $92.81 $113,322 - $131,418
-1,416 Reduced 8.62%
15,003 $1.38 Million
Q4 2022

Jan 11, 2023
SELL
$75.55 - $92.52 $52,885 - $64,764
-700 Reduced 4.09%
16,419 $0
Q3 2022

Oct 11, 2022
SELL
$74.61 - $87.26 $28,650 - $33,507
-384 Reduced 2.19%
17,119 $1.3 Million
Q2 2022

Aug 10, 2022
SELL
$80.52 - $93.75 $89,699 - $104,437
-1,114 Reduced 5.98%
17,503 $1.48 Million
Q1 2022

Apr 06, 2022
SELL
$80.11 - $90.62 $53,433 - $60,443
-667 Reduced 3.46%
18,617 $1.63 Million
Q4 2021

Feb 01, 2022
SELL
$79.7 - $88.13 $511,913 - $566,058
-6,423 Reduced 24.99%
19,284 $1.69 Million
Q3 2021

Oct 27, 2021
BUY
$81.78 - $95.14 $31,485 - $36,628
385 Added 1.52%
25,707 $2.1 Million
Q2 2021

Aug 09, 2021
SELL
$85.24 - $94.15 $179,004 - $197,715
-2,100 Reduced 7.66%
25,322 $2.31 Million
Q1 2021

Apr 20, 2021
BUY
$83.5 - $98.47 $66,382 - $78,283
795 Added 2.99%
27,422 $2.39 Million
Q4 2020

Jan 28, 2021
BUY
$78.07 - $94.43 $46,529 - $56,280
596 Added 2.29%
26,627 $2.51 Million
Q3 2020

Nov 02, 2020
BUY
$82.14 - $91.0 $29,898 - $33,124
364 Added 1.42%
26,031 $2.24 Million
Q2 2020

Jul 17, 2020
BUY
$80.93 - $91.1 $1,861 - $2,095
23 Added 0.09%
25,667 $2.23 Million
Q1 2020

Jun 05, 2020
BUY
$70.67 - $99.01 $102,259 - $143,267
1,447 Added 5.98%
25,644 $2.24 Million
Q4 2019

Jan 24, 2020
SELL
$84.35 - $95.37 $1,012 - $1,144
-12 Reduced 0.05%
24,197 $2.29 Million
Q3 2019

Nov 12, 2019
SELL
$85.54 - $94.26 $1,368 - $1,508
-16 Reduced 0.07%
24,209 $2.1 Million
Q2 2019

Aug 09, 2019
SELL
$75.4 - $92.8 $22,997 - $28,304
-305 Reduced 1.24%
24,225 $2.2 Million
Q1 2019

May 02, 2019
BUY
$75.32 - $86.15 $7,080 - $8,098
94 Added 0.38%
24,530 $2.36 Million
Q4 2018

Feb 06, 2019
BUY
$73.66 - $82.02 $45,742 - $50,934
621 Added 2.61%
24,436 $2.1 Million
Q3 2018

Oct 23, 2018
SELL
$66.94 - $77.43 $64,262 - $74,332
-960 Reduced 3.87%
23,815 $2.05 Million
Q2 2018

Jul 31, 2018
SELL
$64.91 - $73.36 $41,672 - $47,097
-642 Reduced 2.53%
24,775 $1.87 Million
Q1 2018

Apr 27, 2018
SELL
$70.39 - $84.15 $85,594 - $102,326
-1,216 Reduced 4.57%
25,417 $2.06 Million
Q4 2017

Feb 02, 2018
BUY
$72.33 - $77.64 $1.51 Million - $1.62 Million
20,849 Added 360.46%
26,633 $2.24 Million
Q3 2017

Nov 03, 2017
SELL
$74.14 - $77.27 $12,233 - $12,749
-165 Reduced 2.77%
5,784 $497,000
Q2 2017

Apr 03, 2018
SELL
N/A
-89 Reduced 1.47%
5,949 $497,000
Q1 2017

Apr 03, 2018
BUY
N/A
6,038
6,038 $448,000

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Telemus Capital, LLC Portfolio

Follow Telemus Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Telemus Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email